Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient

Clinical trial NCT01424436 · COMPLETED

Trial details

NCT number: NCT01424436
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2010-05-19
Primary completion: 2011-12-08
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.